Get the Stockscreener App
10.52
4.62%
-0.51
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Forecast
The Direxion Daily S&P Biotech Bear 3X Shares (LABD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $424.21, representing a +3,932% increase from the current price of $10.52. The highest analyst price target is $407.34, and the lowest is $441.08.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LABD Price Target
Average 388.15
(+3,590% Upside)
Is Direxion Daily S&P Biotech Bear 3X Shares (LABD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.98 | Neutral |
| STOCH(9,6) | 70.25 | Neutral |
| STOCHRSI(14) | 50.32 | Neutral |
| MACD(12,26) | 0.7602 | Buy |
| ADX(14) | 29.50 | Buy |
| William %R | -26.20 | Neutral |
| CCI(14) | 81.62 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.31
Buy
|
10.16
Buy
|
| MA20 |
9.309
Buy
|
9.5152
Buy
|
| MA50 |
8.0448
Buy
|
9.0508
Buy
|
| MA100 |
9.2572
Buy
|
10.31
Buy
|
| MA200 |
14.22
Sell
|
12.43
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, LABD could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on LABD, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.98 indicates that LABD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 70.25 indicates that LABD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.32 indicates that LABD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.5 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 81.62 indicates that LABD is still overbought but not to an extreme extent.
Long-term LABD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Direxion Daily S&P Biotech Bear 3X Shares financial reports and earnings history, Direxion Daily S&P Biotech Bear 3X Shares (LABD) stock could reach $1,256.47 by 2030, $466.10 by 2040 and $1,806.21 by 2050. See the projected annual prices until 2050 of the Direxion Daily S&P Biotech Bear 3X Shares stock below:
- Direxion Daily S&P Biotech Bear 3X Shares (LABD) is expected to reach an average price of $60.41 in 2035, with a high prediction of $92.45 and a low estimate of $64.23. This indicates an $474.21% rise from the last recorded price of $10.52.
- Direxion Daily S&P Biotech Bear 3X Shares (LABD) stock is projected to chart a bullish course in 2040, with an average price target of $424.23, representing an $3,933% surge from its current level. The forecast ranges from a conservative $426.84 to a sky-high $466.10.
- Our analysts predict Direxion Daily S&P Biotech Bear 3X Shares (LABD) to jump 9,302% by 2045, soaring from $990.76 to an average price of $989.14, potentially reaching $1,030.81. While $990.76 is the low estimate, the potential upside is significant.
- Direxion Daily S&P Biotech Bear 3X Shares (LABD) stock is expected to climb by 2050, reaching an average of $1,741.99, a $16,459% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,806.21 and $1,747.84, respectively, highlighting the market's uncertainty.
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Year by Year Forecast
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2024
Our forecast for LABD stock price in 2024 now indicates an average price target of $269.90 with a high forecast of $481.11 and a low forecast of $58.69. The average prediction reflects an increase of +2,466% from the last recorded price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $427.88 | $441.08 | $407.34 | +3,967% |
| June, 2024 | $325.85 | $395.91 | $374.82 | +2,997% |
| July, 2024 | $451.76 | $391.59 | $449.16 | +4,194% |
| August, 2024 | $432.73 | $443.39 | $421.90 | +4,013% |
| September, 2024 | $342.24 | $362.44 | $391.07 | +3,153% |
| October, 2024 | $271.81 | $353.38 | $367.87 | +2,484% |
| November, 2024 | $313.78 | $285.15 | $266.38 | +2,883% |
| December, 2024 | $390.09 | $360.52 | $368.49 | +3,608% |
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2025
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) is expected to reach an average price of $455.97 in 2025, with a high prediction of $567.15 and a low estimate of $344.79. This indicates an +4,234% rise from the last recorded price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $491.26 | $431.03 | $481.26 | +4,570% |
| February, 2025 | $464.93 | $486.03 | $491.14 | +4,319% |
| March, 2025 | $479.54 | $447.60 | $449.55 | +4,458% |
| April, 2025 | $429.51 | $461.08 | $475.28 | +3,983% |
| May, 2025 | $397.48 | $344.79 | $379.42 | +3,678% |
| June, 2025 | $533.79 | $401.82 | $533.79 | +4,974% |
| July, 2025 | $571.56 | $526.13 | $561.76 | +5,333% |
| August, 2025 | $569.72 | $563.78 | $553.84 | +5,316% |
| September, 2025 | $574.84 | $572.20 | $567.15 | +5,364% |
| October, 2025 | $551.80 | $558.80 | $559.88 | +5,145% |
| November, 2025 | $532.22 | $544.14 | $548.55 | +4,959% |
| December, 2025 | $531.16 | $535.31 | $533.46 | +4,949% |
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2026
The predicted value for Direxion Daily S&P Biotech Bear 3X Shares (LABD) in 2026 is set at an average of $476.83. Estimates vary from a peak of $537.54 to a trough of $416.13, indicating an +4,433% surge from the present price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $525.86 | $532.33 | $537.54 | +4,899% |
| February, 2026 | $535.25 | $535.03 | $531.20 | +4,988% |
| March, 2026 | $531.33 | $532.49 | $531.14 | +4,951% |
| April, 2026 | $521.04 | $522.41 | $523.96 | +4,853% |
| May, 2026 | $512.04 | $513.71 | $516.77 | +4,767% |
| June, 2026 | $489.41 | $495.14 | $503.67 | +4,552% |
| July, 2026 | $477.19 | $479.19 | $485.04 | +4,436% |
| August, 2026 | $460.88 | $462.79 | $472.73 | +4,281% |
| September, 2026 | $452.72 | $454.45 | $456.28 | +4,203% |
| October, 2026 | $440.91 | $442.27 | $448.97 | +4,091% |
| November, 2026 | $422.03 | $424.24 | $432.85 | +3,912% |
| December, 2026 | $415.17 | $416.13 | $416.89 | +3,846% |
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Direxion Daily S&P Biotech Bear 3X Shares (LABD) is $325.28, with a high forecast of $410.89 and a low forecast of $239.66. This indicates an +2,992% increase from the last price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $399.73 | $402.80 | $410.89 | +3,700% |
| February, 2027 | $387.00 | $387.44 | $395.04 | +3,579% |
| March, 2027 | $368.37 | $371.56 | $382.82 | +3,402% |
| April, 2027 | $357.70 | $358.35 | $362.51 | +3,300% |
| May, 2027 | $320.30 | $330.64 | $352.55 | +2,945% |
| June, 2027 | $316.03 | $320.50 | $313.33 | +2,904% |
| July, 2027 | $292.97 | $303.56 | $307.96 | +2,685% |
| August, 2027 | $295.26 | $295.26 | $294.05 | +2,707% |
| September, 2027 | $256.57 | $270.80 | $289.11 | +2,339% |
| October, 2027 | $250.00 | $250.15 | $246.27 | +2,276% |
| November, 2027 | $251.58 | $239.66 | $239.74 | +2,291% |
| December, 2027 | $247.32 | $245.39 | $242.56 | +2,251% |
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2028
In 2028, Direxion Daily S&P Biotech Bear 3X Shares (LABD) is projected to reach an average price of $172.50, with a high projection of $242.73 and a low estimate of $102.27. This indicates an +1,540% rise from the last price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $238.88 | $243.29 | $242.73 | +2,171% |
| February, 2028 | $228.06 | $228.59 | $234.39 | +2,068% |
| March, 2028 | $210.74 | $214.12 | $221.45 | +1,903% |
| April, 2028 | $202.13 | $203.29 | $205.07 | +1,821% |
| May, 2028 | $189.16 | $189.27 | $195.89 | +1,698% |
| June, 2028 | $175.87 | $177.52 | $185.01 | +1,572% |
| July, 2028 | $165.76 | $166.10 | $170.80 | +1,476% |
| August, 2028 | $152.55 | $152.70 | $161.41 | +1,350% |
| September, 2028 | $133.40 | $138.98 | $146.60 | +1,168% |
| October, 2028 | $120.76 | $122.02 | $129.86 | +1,048% |
| November, 2028 | $114.21 | $115.08 | $118.48 | +985.68% |
| December, 2028 | $102.27 | $102.27 | $109.85 | +872.17% |
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2029
The 2029 price forecast for Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) is $678.49 on average, with a high prediction of $1,353.51 and a low estimate of $3.476. This represents an +6,350% increase from the previous price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $84.83 | $85.74 | $98.87 | +706.40% |
| February, 2029 | $74.00 | $74.08 | $81.57 | +603.45% |
| March, 2029 | $58.76 | $59.50 | $69.24 | +458.57% |
| April, 2029 | $39.39 | $42.64 | $55.45 | +274.45% |
| May, 2029 | $21.60 | $26.35 | $35.27 | +105.34% |
| June, 2029 | $10.73 | $15.27 | $15.30 | +2.00% |
| July, 2029 | $5.9715 | $6.8915 | $10.12 | -43.24% |
| August, 2029 | $964.98 | $3.476 | $913.78 | +9,073% |
| September, 2029 | $1,264.12 | $1,087.27 | $1,215.44 | +11,916% |
| October, 2029 | $1,303.74 | $1,289.21 | $1,266.49 | +12,293% |
| November, 2029 | $1,371.48 | $1,373.43 | $1,353.51 | +12,937% |
| December, 2029 | $1,264.25 | $1,362.90 | $1,339.42 | +11,918% |
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) Price Forecast for 2030
Direxion Daily S&P Biotech Bear 3X Shares Stock (LABD) is expected to reach an average price of $1,164.31 in 2030, with a high forecast of $1,267.72 and a low forecast of $1,060.90. This signifies an +10,968% surge from the last price of $10.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1,240.64 | $1,287.16 | $1,256.47 | +11,693% |
| February, 2030 | $1,221.38 | $1,222.38 | $1,185.41 | +11,510% |
| March, 2030 | $1,270.32 | $1,227.27 | $1,267.72 | +11,975% |
| April, 2030 | $1,202.74 | $1,250.94 | $1,237.40 | +11,333% |
| May, 2030 | $1,133.28 | $1,153.48 | $1,150.83 | +10,673% |
| June, 2030 | $1,050.62 | $1,141.36 | $1,149.73 | +9,887% |
| July, 2030 | $1,114.84 | $1,060.90 | $1,073.56 | +10,497% |
| August, 2030 | $1,141.38 | $1,130.12 | $1,119.78 | +10,750% |
| September, 2030 | $1,234.40 | $1,179.26 | $1,222.60 | +11,634% |
| October, 2030 | $1,199.54 | $1,212.74 | $1,224.08 | +11,302% |
| November, 2030 | $1,191.07 | $1,162.19 | $1,170.26 | +11,222% |
| December, 2030 | $944.50 | $1,101.60 | $1,183.76 | +8,878% |
0.06%
1.82%
Cap:
|
Volume (24h):